Gene · 9656
Papers2,704
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,704
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Maintaining Genome Integrity: Protein Kinases and Phosphatases Orchestrate the Balancing Act of DNA Double-Strand Breaks Repair in Cancer. | Int J Mol Sci | 2023 | 37373360 | PubTator, text mining | PubMed |
| Epigenetic and Immunological Features of Bladder Cancer. | Int J Mol Sci | 2023 | 37373000 | PubTator, text mining | PubMed |
| Prognostic analysis of patients with breast cancer based on tumor mutational burden and DNA damage repair genes. | Front Oncol | 2023 | 37350936 | PubTator, text mining | PubMed |
| Potential of Synthetic and Natural Compounds as Novel Histone Deacetylase Inhibitors for the Treatment of Hematological Malignancies. | Cancers (Basel) | 2023 | 37345145 | PubTator, text mining | PubMed |
| Systematic analysis of the molecular and biophysical properties of key DNA damage response factors. | Elife | 2023 | 37341699 | PubTator, text mining | PubMed |
| Recurrent/Metastatic Nasopharyngeal Carcinoma Treatment from Present to Future: Where Are We and Where Are We Heading? | Curr Treat Options Oncol | 2023 | 37318724 | PubTator, text mining | PubMed |
| Mitotic tethering enables inheritance of shattered micronuclear chromosomes. | Nature | 2023 | 37316668 | PubTator, text mining | PubMed |
| Chromatin-Associated SIN3B Protects Cancer Cells from Genotoxic Stress-Induced Apoptosis and Dictates DNA Damage Repair Pathway Choice. | Mol Cancer Res | 2023 | 37314748 | PubTator, text mining | PubMed |
| SIRT1 regulates DNA damage signaling through the PP4 phosphatase complex. | Nucleic Acids Res | 2023 | 37309898 | PubTator, text mining | PubMed |
| An AlphaFold2 map of the 53BP1 pathway identifies a direct SHLD3-RIF1 interaction critical for shieldin activity. | EMBO Rep | 2023 | 37306046 | PubTator, text mining | PubMed |
| A syndrome featuring developmental disorder of the nervous system induced by a novel mutation in the TCF20 gene, rarely concurrent immune disorders: a case report. | Front Genet | 2023 | 37303953 | PubTator, text mining | PubMed |
| Heritable transcriptional defects from aberrations of nuclear architecture. | Nature | 2023 | 37286600 | PubTator, text mining | PubMed |
| FIRRM/C1orf112 mediates resolution of homologous recombination intermediates in response to DNA interstrand crosslinks. | Sci Adv | 2023 | 37256941 | PubTator, text mining | PubMed |
| WWOX binds MERIT40 and modulates its function in homologous recombination, implications in breast cancer. | Cancer Gene Ther | 2023 | 37248434 | PubTator, text mining | PubMed |
| GPR19 Coordinates Multiple Molecular Aspects of Stress Responses Associated with the Aging Process. | Int J Mol Sci | 2023 | 37239845 | PubTator, text mining | PubMed |
| Key elements of cellular senescence involve transcriptional repression of mitotic and DNA repair genes through the p53-p16/RB-E2F-DREAM complex. | Aging (Albany NY) | 2023 | 37219418 | PubTator, text mining | PubMed |
| Current proteomics methods applicable to dissecting the DNA damage response. | NAR Cancer | 2023 | 37213254 | PubTator, text mining | PubMed |
| Pharmacological impact of microRNAs in head and neck squamous cell carcinoma: Prevailing insights on molecular pathways, diagnosis, and nanomedicine treatment. | Front Pharmacol | 2023 | 37205904 | PubTator, text mining | PubMed |
| Novel CDK12/13 Inhibitors AU-15506 and AU-16770 Are Potent Anti-Cancer Agents in EGFR Mutant Lung Adenocarcinoma with and without Osimertinib Resistance. | Cancers (Basel) | 2023 | 37190191 | PubTator, text mining | PubMed |
| Residual Foci of DNA Damage Response Proteins in Relation to Cellular Senescence and Autophagy in X-Ray Irradiated Fibroblasts. | Cells | 2023 | 37190118 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9656/papers?page=10